In comparison, risk-stratification-based approaches identify individuals with greater risks of developing CHD based on an elevated FRS, PCE, CAC, or CRP level, but they may not sufficiently lower risks across the entire population. The gene discussed is CRP; the disease is coronary artery disorder.